Jay I. Goodman

Affiliations: 
Michigan State University, East Lansing, MI 
Area:
Toxicology, Molecular Biology, Oncology
Google:
"Jay Goodman"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Goodman JI. (2018) Goodbye to the bioassay. Toxicology Research. 7: 558-564
Goodman JI. (2017) Incorporation of an Epigenetic Evaluation into Safety Assessment: What we First Need to Know. Current Opinion in Toxicology. 3: 20-24
Felter SP, Foreman JE, Boobis A, et al. (2017) Human relevance of rodent liver tumors: Key insights from a Toxicology Forum workshop on nongenotoxic modes of action. Regulatory Toxicology and Pharmacology : Rtp
Boobis A, Brown P, Cronin MTD, et al. (2017) Origin of the TTC values for compounds that are genotoxic and/or carcinogenic and an approach for their re-evaluation. Critical Reviews in Toxicology. 1-23
Wolf DC, Bachman A, Barrett G, et al. (2015) Illustrative case using the RISK21 roadmap and matrix: prioritization for evaluation of chemicals found in drinking water. Critical Reviews in Toxicology. 1-11
Currie RA, Peffer RC, Goetz AK, et al. (2014) Phenobarbital and propiconazole toxicogenomic profiles in mice show major similarities consistent with the key role that constitutive androstane receptor (CAR) activation plays in their mode of action. Toxicology. 321: 80-8
Luisier R, Unterberger EB, Goodman JI, et al. (2014) Computational modeling identifies key gene regulatory interactions underlying phenobarbital-mediated tumor promotion. Nucleic Acids Research. 42: 4180-95
Elcombe CR, Peffer RC, Wolf DC, et al. (2014) Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator. Critical Reviews in Toxicology. 44: 64-82
Lempiäinen H, Couttet P, Bolognani F, et al. (2013) Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion. Toxicological Sciences : An Official Journal of the Society of Toxicology. 131: 375-86
Shane BS, Zeiger E, Piegorsch WW, et al. (2012) Re-evaluation of the Big Blue® mouse assay of propiconazole suggests lack of mutagenicity. Environmental and Molecular Mutagenesis. 53: 1-9
See more...